EUVIMEDEUVIMED entdecken
Open Access

Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T‐cell therapy in pediatrics

Angela Steineck iD, Sara K Silbert, Kallie Palm, Jordyn Nepper, Dagny Vaughn, Kelly Shipman, Haneen Shalabi, Lori Wiener iD, Liam Comiskey, Jennifer M Knight, Deena Levine

Pediatric Blood & Cancer · 2024-09 · 71 (9)

DOI: 10.1002/pbc.31092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 12.06.2024. Verfasst von Angela Steineck und 10 weiteren Autor:innen. Beteiligte Einrichtung: MACC Fund Center for Cancer and Blood Disorders, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: St. Baldrick's Foundation, T32 Training, American Lebanese Syrian Associated Charities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chimeric antigen receptor (CAR) T‐cell therapy provides promising outcomes in relapsed/refractory B acute lymphoblastic leukemia (ALL), yet still carries high toxicity rates and relatively poor long‐term survival. Efficacy has yet to be demonstrated in other diagnoses while toxicity and risk profiles remain formidable. To date, treatment‐related symptom burden is gleaned from clinical trial toxicity reports; the patient perspective remains understudied.

Methods

English‐ or Spanish‐speaking patients (ages 8–25 years) undergoing CAR T‐cell therapy for any malignancy and their primary caregivers were recruited from Seattle Children's Hospital (SCH), St. Jude Children's Research Hospital (SJCRH), and the Pediatric Oncology Branch of the National Cancer Institute (NCI). Both patient and caregiver completed semi‐structured dyadic interviews 3 months post treatment. We used directed content analysis for codebook development and thematic network analysis for inductive qualitative analysis.

Results

Twenty families completed interviews (13 patients, 15 parents). Patients were a median age 16.5 years, predominantly female (65%), White (75%), and diagnosed with ALL (75%). Global themes included “A clear decision,” “Coping with symptoms,” and “Unforeseen psychosocial challenges.” When families were asked to describe the “most challenging part of treatment,” most described “the unknown.” Most reported “the symptoms really weren't that bad,” even among patients hospitalized for severe toxicity events. Fatigue, pain, and nausea were the most prevalent symptoms. Importantly, only one family would have chosen a different therapy, if given another opportunity.

Conclusions

Although physical symptoms were largely tolerable, recognizing supportive care opportunities remains imperative, particularly psychosocial concerns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveHumansFemaleMaleAdolescentChildAdultYoung AdultReceptors, Chimeric AntigenCaregiversFollow-Up StudiesQualitative ResearchQuality of Life

Stichwörter der Autor:innen

adolescent and young adultcancerpalliative care

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • MACC Fund Center for Cancer and Blood Disorders, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA.
  • Medical School, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • College of Medicine, Health Sciences Center, University of Tennessee, Memphis, Tennessee, USA.
  • Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Psychosocial Oncology & Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

ORCID-Profile: Angela Steineck, Lori Wiener

Förderung

  • St. Baldrick's Foundation
  • T32 Training
  • American Lebanese Syrian Associated Charities
  • Intramural Program of the National Cancer Institute
  • NCI NIH HHS
  • NIH HHS
  • Conquer Cancer Foundation
  • NHLBI NIH HHS

Zitieren

APA

Steineck, A., Silbert, S. K., Palm, K., Nepper, J., Vaughn, D., Shipman, K., Shalabi, H., Wiener, L., Comiskey, L., Knight, J. M., & Levine, D. (2024). Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T‐cell therapy in pediatrics. Pediatric Blood & Cancer, 71(9). https://doi.org/10.1002/pbc.31092

Vancouver

Steineck A, Silbert SK, Palm K, Nepper J, Vaughn D, Shipman K, et al. Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T‐cell therapy in pediatrics. Pediatric Blood & Cancer. 2024;71(9). doi:10.1002/pbc.31092

BibTeX
@article{Steineck2024,
  author = {Steineck, Angela and Silbert, Sara K and Palm, Kallie and Nepper, Jordyn and Vaughn, Dagny and Shipman, Kelly and Shalabi, Haneen and Wiener, Lori and Comiskey, Liam and Knight, Jennifer M and Levine, Deena},
  title = {Weathering the storm when the end of the road is near: A qualitative analysis of supportive care needs during CAR T‐cell therapy in pediatrics},
  journal = {Pediatric Blood & Cancer},
  year = {2024},
  volume = {71},
  number = {9},
  doi = {10.1002/pbc.31092}
}
Kostenlos starten →